We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Sotera Health Co (SHC) USD0.01

Sell:$10.89 Buy:$10.90 Change: $0.12 (1.12%)
NASDAQ:0.52%
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$10.89
Buy:$10.90
Change: $0.12 (1.12%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$10.89
Buy:$10.90
Change: $0.12 (1.12%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Contact details

Address:
9100 South Hills Blvd
Suite 300, Suite 300
BROADVIEW HEIGHTS
44147
United States
Telephone:
+1 (440) 2621410
Website:
https://soterahealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SHC
ISIN:
US83601L1026
Market cap:
$3.04 billion
Shares in issue:
283.07 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Michael Petras
    Chairman of the Board, Chief Executive Officer
  • Jonathan Lyons
    Chief Financial Officer, Senior Vice President
  • Michael Rutz
    President of Sterigenics
  • Alexander Dimitrief
    Senior Vice President, General Counsel, Secretary
  • Matthew Klaben
    Deputy General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.